气喘药物市场：按产品、按应用分类 - 2024-2030 年全球预测

预计2023年气喘治疗市场规模为188.4亿美元，预计2024年将达204.4亿美元，2030年将达到335.9亿美元，复合年增长率为8.61%。

全球气喘药物市场

FPNV定位矩阵

FPNV定位矩阵对于评估气喘治疗市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对气喘治疗药物市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场并分析其在成熟细分市场的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-气喘治疗药物市场的市场规模与预测是多少？

2-气喘治疗药物市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3-气喘治疗药物市场的技术趋势和法律规范是什么？

4-气喘治疗药物市场主要供应商的市场占有率是多少？

5-进入气喘药物市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

• 市场动态
  • 促进因素
    • 全球气喘盛行率上升
    • FDA核准扩大气喘治疗的接受度
    • 政府努力提高人们对气喘药物的认识
  • 抑制因素
    • 气喘治疗费用高
  • 机会
    • 气喘药物开发的技术进步
    • 呼吸系统疾病治疗不断取得进展
  • 任务
    • 政府对气喘药物的核准有严格的规定
• 市场区隔分析
• 市场趋势分析
• 高通膨的累积效应
• 波特五力分析
• 价值炼和关键路径分析
• 法律规范

第六章气喘治疗药物市场：副产品

• 长期控制药物
• 治疗过敏性气喘的药物
• 立即有效药物（抢救药物）

第七章气喘治疗药物市场：依应用分类

• 医院药房
• 网路药房
• 零售药房

第 8 章：美洲气喘药物市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第九章亚太气喘药物市场

• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第十章 欧洲、中东和非洲气喘药物市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第十一章竞争形势

• FPNV定位矩阵
• 市场占有率分析：主要企业
• 主要企业竞争情境分析

第12章竞争产品组合

• 主要公司简介
  • ALK-Abello A/S
  • Amphastar Pharmaceuticals, Inc.
  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • CHIESI Farmaceutici SpA
  • Cipla Limited
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Hetero Labs Limited
  • Lallemand Inc.
  • Merck KGaA
  • Mundipharma International Limited
  • NIOX Group PLC
  • Novartis AG
  • OPKO Health, Inc.
  • Sanner GmbH
  • Sanofi SA
  • Sunovion Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Verona Pharma PLC
  • Viatris, Inc.
• 主要产品系列

第十三章附录

• 讨论指南
• 关于许可证和定价

[199 Pages Report] The Asthma Drugs Market size was estimated at USD 18.84 billion in 2023 and expected to reach USD 20.44 billion in 2024, at a CAGR 8.61% to reach USD 33.59 billion by 2030.

Global Asthma Drugs Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Asthma Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Asthma Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Asthma Drugs Market, highlighting leading vendors and their innovative profiles. These include ALK-Abello A/S, Amphastar Pharmaceuticals, Inc., AstraZeneca PLC, Boehringer Ingelheim International GmbH, CHIESI Farmaceutici S.p.A., Cipla Limited, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Hetero Labs Limited, Lallemand Inc., Merck KGaA, Mundipharma International Limited, NIOX Group PLC, Novartis AG, OPKO Health, Inc., Sanner GmbH, Sanofi S.A., Sunovion Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Verona Pharma PLC, and Viatris, Inc..

Market Segmentation & Coverage

This research report categorizes the Asthma Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Long-Term Control Medications
  • Medications for Allergy-Induced Asthma
  • Quick-Relief Medications (Rescue Medications)
• Application
  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Asthma Drugs Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Asthma Drugs Market?

3. What are the technology trends and regulatory frameworks in the Asthma Drugs Market?

4. What is the market share of the leading vendors in the Asthma Drugs Market?

5. Which modes and strategic moves are suitable for entering the Asthma Drugs Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Asthma Drugs Market, by Region

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of asthma globally
    • 5.1.1.2. Increasing acceptance of asthma drugs with approval from FDA
    • 5.1.1.3. Government initiatives to spread the awareness of asthma drugs
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of asthma treatments
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancement in the development of asthma drugs
    • 5.1.3.2. Ongoing advancements in respiratory disease treatments
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent government regulations for the approval of asthma drug
• 5.2. Market Segmentation Analysis
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework

6. Asthma Drugs Market, by Product

• 6.1. Introduction
• 6.2. Long-Term Control Medications
• 6.3. Medications for Allergy-Induced Asthma
• 6.4. Quick-Relief Medications (Rescue Medications)

7. Asthma Drugs Market, by Application

• 7.1. Introduction
• 7.2. Hospital Pharmacy
• 7.3. Online Pharmacy
• 7.4. Retail Pharmacy

8. Americas Asthma Drugs Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Asthma Drugs Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Asthma Drugs Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
• 11.2. Market Share Analysis, By Key Player
• 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

• 12.1. Key Company Profiles
  • 12.1.1. ALK-Abello A/S
  • 12.1.2. Amphastar Pharmaceuticals, Inc.
  • 12.1.3. AstraZeneca PLC
  • 12.1.4. Boehringer Ingelheim International GmbH
  • 12.1.5. CHIESI Farmaceutici S.p.A.
  • 12.1.6. Cipla Limited
  • 12.1.7. F. Hoffmann-La Roche Ltd.
  • 12.1.8. GlaxoSmithKline PLC
  • 12.1.9. Hetero Labs Limited
  • 12.1.10. Lallemand Inc.
  • 12.1.11. Merck KGaA
  • 12.1.12. Mundipharma International Limited
  • 12.1.13. NIOX Group PLC
  • 12.1.14. Novartis AG
  • 12.1.15. OPKO Health, Inc.
  • 12.1.16. Sanner GmbH
  • 12.1.17. Sanofi S.A.
  • 12.1.18. Sunovion Pharmaceuticals Inc.
  • 12.1.19. Teva Pharmaceutical Industries Ltd.
  • 12.1.20. Verona Pharma PLC
  • 12.1.21. Viatris, Inc.
• 12.2. Key Product Portfolio

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. ASTHMA DRUGS MARKET RESEARCH PROCESS
• FIGURE 2. ASTHMA DRUGS MARKET SIZE, 2023 VS 2030
• FIGURE 3. ASTHMA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. ASTHMA DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. ASTHMA DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. ASTHMA DRUGS MARKET DYNAMICS
• FIGURE 7. ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 10. ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. AMERICAS ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 12. AMERICAS ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 14. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ASTHMA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
• FIGURE 20. ASTHMA DRUGS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

• TABLE 1. ASTHMA DRUGS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. ASTHMA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ASTHMA DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 6. ASTHMA DRUGS MARKET SIZE, BY LONG-TERM CONTROL MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. ASTHMA DRUGS MARKET SIZE, BY MEDICATIONS FOR ALLERGY-INDUCED ASTHMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. ASTHMA DRUGS MARKET SIZE, BY QUICK-RELIEF MEDICATIONS (RESCUE MEDICATIONS), BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 10. ASTHMA DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. ASTHMA DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. ASTHMA DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. AMERICAS ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 16. ARGENTINA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. BRAZIL ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. CANADA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. CANADA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. MEXICO ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 27. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. AUSTRALIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. CHINA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. CHINA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. INDIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. INDIA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. INDONESIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. JAPAN ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. MALAYSIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. PHILIPPINES ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. SINGAPORE ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. SOUTH KOREA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. TAIWAN ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. THAILAND ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. VIETNAM ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 57. DENMARK ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. EGYPT ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. FINLAND ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. FRANCE ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. GERMANY ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. ISRAEL ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. ITALY ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. ITALY ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. NETHERLANDS ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. NIGERIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. NORWAY ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. POLAND ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. POLAND ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. QATAR ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. QATAR ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. RUSSIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. SAUDI ARABIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH AFRICA ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. SPAIN ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SWEDEN ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. SWITZERLAND ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. TURKEY ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. UNITED ARAB EMIRATES ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. UNITED KINGDOM ASTHMA DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM ASTHMA DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. ASTHMA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
• TABLE 100. ASTHMA DRUGS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 101. ASTHMA DRUGS MARKET LICENSE & PRICING